Dow Down 1.10% Nasdaq Down 1.82%

Advaxis, Inc. (ADXS)

-NasdaqCM
5.91 Down 0.44(6.93%) 3:59PM EST
|After Hours : 5.60 Down 0.31 (5.25%) 6:28PM EST
Prev Close:6.35
Open:6.20
Bid:4.77 x 300
Ask:7.10 x 400
1y Target Est:28.50
Beta:-0.258312
Next Earnings Date:N/A
Day's Range:5.71 - 6.33
52wk Range:5.71 - 30.13
Volume:947,106
Avg Vol (3m):937,484
Market Cap:199.69M
P/E (ttm):N/A
EPS (ttm):-1.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ADXS

Comparison

Symbol% ChgMkt Cap
ADXSDown 6.93%199.69M
VICLDown 0.18%30.40M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Oct-16) :-1.80
Quarterly EPS Est (Jan-16) :-0.41
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback